State Street Corp Spero Therapeutics, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Spero Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 130,511 shares of SPRO stock, worth $122,680. This represents 0.0% of its overall portfolio holdings.

Number of Shares

130,511

Previous 130,511 -0.0%

Holding current value

$122,680

Previous $169,000 2.96%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$1.2 - $1.63 $23,760 - $32,273	19,800 Added 17.88%	130,511 $157,000
Q4 2022 Feb 14, 2023	BUY	$1.55 - $2.12 $30,070 - $41,128	19,400 Added 21.25%	110,711 $191,000
Q3 2022 Nov 15, 2022	SELL	$0.68 - $2.2 $6,169 - $19,960	-9,073 Reduced 9.04%	91,311 $183,000
Q2 2022 Aug 15, 2022	SELL	$0.74 - $7.44 $293,632 - $2.95 Million	-396,801 Reduced 79.81%	100,384 $74,000
Q1 2022 May 16, 2022	SELL	$7.87 - $15.15 $2.73 Million - $5.25 Million	-346,770 Reduced 41.09%	497,185 $4.33 Million
Q4 2021 Feb 14, 2022	BUY	$13.09 - $18.77 $540,145 - $774,525	41,264 Added 5.14%	843,955 $13.5 Million
Q3 2021 Nov 15, 2021	SELL	$13.03 - $19.51 $104,852 - $156,996	-8,047 Reduced 0.99%	802,691 $14.8 Million
Q2 2021 Aug 16, 2021	SELL	$12.22 - $15.79 $6.67 Million - $8.62 Million	-545,805 Reduced 40.23%	810,738 $11.3 Million
Q1 2021 May 17, 2021	BUY	$13.23 - $21.48 $13.5 Million - $21.9 Million	1,017,712 Added 300.36%	1,356,543 $20 Million
Q4 2020 Feb 16, 2021	BUY	$11.65 - $22.07 $620,234 - $1.17 Million	53,239 Added 18.64%	338,831 $6.57 Million
Q3 2020 Nov 10, 2020	SELL	$8.96 - $14.12 $26,718 - $42,105	-2,982 Reduced 1.03%	285,592 $3.19 Million
Q2 2020 Aug 14, 2020	BUY	$7.27 - $14.18 $73,652 - $143,657	10,131 Added 3.64%	288,574 $3.9 Million
Q1 2020 May 11, 2020	BUY	$5.27 - $10.41 $1.47 Million - $2.9 Million	278,443 New	278,443 $2.25 Million

Others Institutions Holding SPRO

# of Institutions

Shares Held

13.9M

Call Options Held

200

Put Options Held

200

View Full List

About Spero Therapeutics, Inc.

Ticker SPRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,067,500
Market Cap $33M
Description
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...

More about SPRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Spero Therapeutics, Inc. Transaction History